Yellow fever vaccine viremia following ablative BM suppression in AML

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author AVELINO-SILVA, V. I. FMUSP-HC
LEAL, F. E. FMUSP-HC
SABINO, E. C. FMUSP-HC
NISHIYA, A. S.
FREIRE, M. da Silva
BLUMM, F.
ROCHA, V.
RODRIGUES, C. A.
NOVIS, Y. S.
KALLAS, E. G. FMUSP-HC
dc.date.issued 2012
dc.identifier.citation BONE MARROW TRANSPLANTATION, v.48, n.7, p.1008-1009, 2012
dc.identifier.issn 0268-3369
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/4077
dc.language.iso eng
dc.publisher NATURE PUBLISHING GROUP
dc.relation.ispartof Bone Marrow Transplantation
dc.rights restrictedAccess
dc.subject.other immune-response; adverse events; 17d; immunization; children; patient; brazil; assays; virus
dc.title Yellow fever vaccine viremia following ablative BM suppression in AML
dc.type article
dc.rights.holder Copyright NATURE PUBLISHING GROUP
dc.description.group LIM/52
dc.description.group LIM/60
dc.identifier.doi 10.1038/bmt.2012.277
dc.identifier.pmid 23334273
dc.type.category letter
dc.type.version publishedVersion
hcfmusp.author AVELINO-SILVA, V. I.:FM:
hcfmusp.author LEAL, F. E.:HC:ICHC
hcfmusp.author SABINO, E. C.:FM:MIP
hcfmusp.author KALLAS, E. G.:FM:MCM
hcfmusp.author.external · NISHIYA, A. S.:Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil; Univ Fed Sao Paulo, Infect Dis Div DIPA, Sao Paulo, Brazil
· FREIRE, M. da Silva:Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil
· BLUMM, F.:Hosp Sirio Libanes, Sao Paulo, Brazil
· ROCHA, V.:Hosp Sirio Libanes, Sao Paulo, Brazil
· RODRIGUES, C. A.:Hosp Sirio Libanes, Sao Paulo, Brazil
· NOVIS, Y. S.:Hosp Sirio Libanes, Sao Paulo, Brazil
hcfmusp.origem.id WOS:000321302300026
hcfmusp.origem.id 2-s2.0-84880237687
hcfmusp.publisher.city LONDON
hcfmusp.publisher.country ENGLAND
hcfmusp.relation.reference · Bae HG, 2008, J INFECT DIS, V197, P1577, DOI 10.1086/587844
· Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P32
· Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7
· Engel AR, 2006, VACCINE, V24, P2803, DOI 10.1016/j.vaccine.2006.01.009
· Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
· Gowda R, 2004, EUR J HAEMATOL, V72, P299, DOI 10.1111/j.1600-0609.2004.00218.x
· Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131
· Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009
· Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026
· Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
· National Institute for Biological Standards and Control, 2008, 1 INT REF PREP ANT F
· Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x
· Pickering LK, 2009, CLIN INFECT DIS, V49, P817, DOI 10.1086/605430
· Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
· Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B
· Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
· Thomas RE, 2012, AM J TROP MED HYG, V86, P359, DOI 10.4269/ajtmh.2012.11-0525
· Yax JA, 2009, J TRAVEL MED, V16, P365, DOI 10.1111/j.1708-8305.2009.00336.x
dc.description.index MEDLINE
hcfmusp.citation.scopus 4
hcfmusp.citation.wos 5
hcfmusp.affiliation.country Brasil


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics